4//SEC Filing
DeMuth Peter 4
Accession 0001601485-25-000016
CIK 0001601485other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:11 PM ET
Size
5.6 KB
Accession
0001601485-25-000016
Insider Transaction Report
Form 4
DeMuth Peter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+44,400→ 44,400 totalExercise: $8.92Exp: 2035-02-03→ Common Stock (44,400 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 25% of the options on the first anniversary of the grant date (February 3, 2026), with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
Elicio Therapeutics, Inc.
CIK 0001601485
Entity typeother
Related Parties
1- filerCIK 0001979163
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:11 PM ET
- Size
- 5.6 KB